🇺🇸 phytomenadione in United States

412 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Nausea — 48 reports (11.65%)
  2. Pyrexia — 47 reports (11.41%)
  3. Vomiting — 47 reports (11.41%)
  4. Off Label Use — 45 reports (10.92%)
  5. Sepsis — 43 reports (10.44%)
  6. Fatigue — 41 reports (9.95%)
  7. Diarrhoea — 38 reports (9.22%)
  8. Acute Kidney Injury — 36 reports (8.74%)
  9. Multiple Organ Dysfunction Syndrome — 34 reports (8.25%)
  10. Ascites — 33 reports (8.01%)

Source database →

Other Cardiovascular approved in United States

Frequently asked questions

Is phytomenadione approved in United States?

phytomenadione does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for phytomenadione in United States?

Instituto Mexicano del Seguro Social is the originator. The local marketing authorisation holder may differ — check the official source linked above.